Latest podcast episode – Tailoring drug therapy to your genes

Research / 03 August 2021

Photo: iStock

Drug Safety Matters dives into the fascinating field of pharmacogenomics and the implications it has for tailored treatments and safer prescribing practices.


Genetic variation is one of the reasons people differ in their response to medicines. Understanding that variation can inform more refined choices of drugs and doses – ultimately preventing undesired side effects. Join us as we discuss past, present and future of pharmacogenomics with Uppsala Monitoring Centre’s Qun-Ying Yue.

 

Subscribe by visiting the Drug Safety Matters website or listen in right here:

 

Read more

Pharmacogenomics group aims to refine patient safety options

Africa integral to evolution of pharmacogenomics research

Related Articles

Artificial intelligence in pharmacovigilance: Harnessing potential, navigating risks

A guide to reporting disproportionality analyses – New podcast episode

Mind the gap: Preventing medication errors after hospital discharge

You may also like

Artificial intelligence in pharmacovigilance: Harnessing potential, navigating risks

AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.

Research / 22 October 2024

A guide to reporting disproportionality analyses – New podcast episode

The READUS-PV statement is the first-ever guide for reports of disproportionality analyses that are replicable, reliable, and reproducible.

Research / 07 October 2024

Mind the gap: Preventing medication errors after hospital discharge

Medication errors are a key pharmacovigilance issue, especially as patients transition between secondary and primary care as they readjust to life outside of hospital.

Research / 09 September 2024